Competition ABM/2022/4
On May 31, 2022, the Medical Research Agency (ABM) announced the Competition: “Competition for the elaboration and development of the innovative solutions in the field of new pharmaceutical forms of authorized medicinal products authorized, generic and biosimilar drugs and ABM/2022/4”. The aim of the Competition is to provide financial support to the entrepreneurs for research […]